SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 53.27 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 9.06 |
| Book Value / Share | 0.12 |
| Price / Book | n/a |
| NCAV ($M) | 7.71 |
| NCAV / Share | 0.10 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.73 |
| Return on Assets (ROA) | -0.71 |
| Return on Equity (ROE) | -1.00 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.99 |
| Current Ratio | 2.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 22.91 |
| Assets | 24.26 |
| Liabilities | 15.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 100,705 | 495,293 | 20.33 | |
| 169,562 | 607,355 | 27.92 | |
| 86,030 | 409,212 | 21.02 | |
| 151,606 | 626,639 | 24.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OCX – OncoCyte Corporation | OKYO – OKYO Pharma Limited |
| ONCO – Onconetix, Inc. | ONVO – Organovo Holdings, Inc. |
| ORGO – Organogenesis Holdings Inc. |
Financial data and stock pages provided by
Fintel.io